3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Multiple Myeloma
70
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma, Mantle-Cell
15
Lymphoma, Follicular
15
Lymphoma, Large B-Cell, Diffuse
14
Leukemia, Myeloid, Acute
14
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma, Non-Hodgkin
12
Recurrence
11
Neoplasms, Plasma Cell
10
Lymphoma
10
Myelodysplastic Syndromes
9
Hodgkin Disease
8
Neoplasms
7
Leukemia
7
Burkitt Lymphoma
7
Waldenstrom Macroglobulinemia
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, B-Cell
6
Sezary Syndrome
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Large-Cell, Immunoblastic
4
Astrocytoma
4
Smoldering Multiple Myeloma
3
Prostatic Neoplasms
3
Oligodendroglioma
3
Melanoma
3
Interventions
dl1520
1
Lenalidomide
1
Fluorouracil
1
Cisplatin
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Lymphoid Interstitial Pneumonia
×
Lenalidomide
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled